Lorcaserin in obesity: minimal benefits and ill-defined harms

BMJ Evid Based Med. 2019 Aug;24(4):145-146. doi: 10.1136/bmjebm-2018-111128. Epub 2019 Jan 30.

Authors

Igho J Onakpoya¹, Jeffrey K Aronson²

Affiliations

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
² Centre for Evidence Based Medicine, University of Oxford, Oxford, UK.

PMID: 30700436
DOI: 10.1136/bmjebm-2018-111128

No abstract available

Keywords: clinical trials.

Publication types

Review
Comment

MeSH terms

Benzazepines
Humans
Obesity*
Overweight*

Substances

Benzazepines
lorcaserin